Vaccine Program Articles & Analysis
14 articles found
By utilizing recombinant DNA technology, scientists can produce vaccines that are more effective and safer for public use. Understanding Recombinant Vaccines Recombinant vaccines are created by inserting genetic material from a pathogen into a host cell. ...
Alfa Cytology has announced pancreatic cancer vaccine development services to improve the efficacy and safety of related vaccines. ...
COVID -19 Vaccine Overview The development of a COVID-19 vaccine by drug manufacturers has been welcomed across the globe. A key concern, however, is the safe distribution of the vaccines worldwide. This may cause some challenges for certain vaccines. ...
Abera’s vaccine delivery platform works as a plug-and-play system where known or novel antigens can be engineered onto our delivery platform to create effective, multivalent vaccines that are cost-effective and fast to produce. We actively work together with academia and industry to enable the use of our vaccine delivery platform in design and development of new vaccines. Many of these ...
The study, funded by the National Institute of Allergy and Infectious Diseases (NIAID) Collaborative Influenza Vaccine Innovation Centers (CIVICs) program will assess safety, tolerability, and immunological response to M2SR. ...
Innovations and Iterations In the consumer tech world, iterations happen very fast, though most inventions are not ‘one and done’ masterpieces: the Dyson cyclone vacuum cleaner made 5,127 prototypes. In the medical device world, development takes longer because of the appropriate and necessary regulations and need for safety. Using an agile approach, but with safety and reliability ...
Childhood vaccinations provide immunity to children against serious infectious diseases before they are exposed to them to prevent illness. Many childhood diseases, such as smallpox and polio, have been almost completely eradicated as a result of widespread, standardized childhood vaccination programs. Some vaccinations, such as ...
All vaccines are temperature sensitive and require the proper environmental conditions to ensure vaccine stability. ...
The effectiveness of vaccines heavily relies on proper vaccine storage conditions. Vaccines are time- and temperature-sensitive. ...
ByAKCP
The effectiveness of vaccines heavily relies on proper vaccine storage conditions. Vaccines are time and temperature sensitive. ...
ByAKCP
Each vaccine needs to be stored in a cool and refrigerated place to ensure its efficiency and effectiveness are maintained during use. Every year, millions of people are vaccinated to strengthen their immunity and protect themselves from infectious diseases. According to the regulations of the World Health Organization (WHO), vaccination is an approved tool for dealing with deadly contagious ...
ByAKCP
Eight candidate vaccines are already being tested in people in clinical trials. Once an effective vaccine (or vaccines) has been identified, it will need to be produced rapidly and on a massive scale—billions of doses. ...
Additional investment can help the many countries that cannot afford vaccines for childhood diseases and are falling behind in their vaccination programs. ...
Therefore, it is imperative that a vaccine be developed based on local circulating subtype and tested for immunogenicity in mice and non-human primate models. This paper is a review of the work done on the development and immunogenicity testing of recombinant DNA (rDNA) and recombinant MVA (rMVA) vaccine candidates in animal models under a ...